Schlenk RF, Harrison CN, Palandri F, De Gobbi M, Itri F, Rampal R, Talaulikar D, Jacoby B, Aslanis V, Slack RJ, Roper JA, Schambye HT, Singh B, Mascarenhas J. GB2064 (lenumlostat) shows preliminary evidence of bone marrow collagen fibrosis reduction with manageable tolerability in JAK inhibitor-refractory myelofibrosis: results from the MYLOX-1 phase IIa study. Haematologica; https://doi.org/10.3324/haematol.2025.289108 [Early view].